Home Newsfeeds Credit Suisse Maintains Neutral on Paramount Global, Raises Price Target to $23

Credit Suisse Maintains Neutral on Paramount Global, Raises Price Target to $23

Credit Suisse analyst Douglas Mitchelson maintains Paramount Global (NASDAQ:PARA) with a Neutral and raises the price target from $20 to $23.

byBenzinga Newsdesk

February 17, 2023

1 minute read

Credit Suisse analyst Douglas Mitchelson maintains Paramount Global (NASDAQ:PARA) with a Neutral and raises the price target from $20 to $23.

Analyst Ratings

Unveiling 5 Analyst Insights On Healthcare Realty Trust

By Benzinga Insights

May 30, 2:00 PM

In the last three months, 5 analysts have published ratings on Healthcare Realty Trust (NYSE:HR), offering a diverse…

Exclusive: Medical Marijuana Patients In Pensacola, FL, Get One More Dispensary To Meet Their Needs

By Nina Zdinjak

May 11, 6:04 AM

Cansortium Inc. (CSE: TIUM.U) (OTCQX: CNTMF), a multi-state cannabis operator running under the FLUENT brand, announced the grand opening of its 31st medical cannabis dispensary in Florida and 34th retail location nationwide.

CNTMF

SeaStar Medical’s Lead Product Candidate, The Selective Cytopheretic Device, Included In Consensus Statement For Pediatric Acute Kidney Injury In First Pediatric Acute Disease Quality Initiative Meeting

By Benzinga Newsdesk

November 7, 1:36 PM

– The SCD is currently being evaluated by the FDA for a Humanitarian Device Exemption (HDE) marketing approval for use in children (> 20 kgs) with AKI – The Company expects the FDA to

ICU